Skip to main content
SpringerLink
Log in

Contraceptive Devices for Women: Implants, Intrauterine Devices and Other Products

  • Chapter
  • First Online:
Medicines For Women

  • 1254 Accesses

Abstract

This chapter focuses on progestogen-only implants and intrauterine devices. These methods have a high effectiveness with pregnancies being rare, however intrauterine devices can be expelled. The inherent safety of both types of device is good. Implants and hormone-releasing intrauterine devices can produce hormonal side effects but also non-contraceptive benefits. The levonorgesetrel intrauterine system is widely used in the treatment of heavy menstrual bleeding. Contraceptive devices often cause changes in menstrual bleeding which may result in discontinuation of the method. There are some risks associated with insertion and removal of implants with scope for their reduction. Perforation of the uterus with intrauterine devices is rare, difficult to prevent but usually relatively straightforward to manage. Return to fertility after all contraceptive devices is rapid.

Transdermal patches and vaginal rings are also mentioned in the chapter. While these non-oral routes of combined hormonal contraception administration are considered to be safe, side effects are generally greater than with oral preparations.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 39.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 54.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abdel-Aleem H, d’Arcangues C, Vogelsong KM, Gaffield ML, Gülmezoglu AM (2013a) Treatment of vaginal bleeding irregularities induced by progestin only contraceptives. Cochrane Database Syst Rev 10, CD003449. doi:10.1002/14651858, CD003449.pub5

    PubMed  Google Scholar 

  • Abou-Setta AM, Houston B, Al-Inany HG, Farquhar C (2006) Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. [Review] [Update of Cochrane Database Syst Rev (4):CD005072; PMID: 17054236]. Cochrane Database Syst Rev 21:CD005072

    Google Scholar 

  • Agrawal A, Robinson C (2003) Spontaneous snapping of an Implanon in two halves in situ. J Fam Plann Reprod Health Care 29(4):238

    PubMed  Google Scholar 

  • Andersson K, Odlind V, Rybo G (1994) Levonorgestrel-releasing and copper-releasing (Nova T) IUDs during five years of use: a randomized comparative trial. Contraception 49:56–72

    CAS  PubMed  Google Scholar 

  • Andersson K, Ryde-Blomqvist E, Lindell K, Odlind V, Milsom I (1998) Perforations with intrauterine devices: report from a Swedish survey. Contraception 57:251–255

    CAS  PubMed  Google Scholar 

  • Aoun J, Dines VA, Stovall DW, Mete M, Nelson CB, Gomez-Lobo V (2014) Effects of age, parity, and device type on complications and discontinuation of intrauterine devices. Obstet Gynecol 123(3):2014

    Google Scholar 

  • Backman T, Rauramo I, Huhtala S, Koskenvuo M (2004) Pregnancy during the use of levonorgestrel intrauterine system. Am J Obstet Gynecol 190:50–54

    CAS  PubMed  Google Scholar 

  • Backman T, Rauramo I, Jaakola K, Inki P, Vaahtera K, Launonen A et al (2005) Use of the levonorgestrel-releasing intrauterine system and breast cancer. Obstet Gynecol 106(4):813–817

    PubMed  Google Scholar 

  • Bahamondes L, Bahamondes MV (2014) New and emerging contraceptives: a state-of-the-art review. Int J Womens Health 6(1):221–34

    PubMed Central  PubMed  Google Scholar 

  • Bahamondes L, Monteiro-Dantas C, Espejo-Arce X, dos Santos Fernandes AM, Lui-Filho JF, Perrotti M et al (2006a) A prospective study of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants. Hum Reprod 21(2):466–470

    CAS  PubMed  Google Scholar 

  • Bahamondes L, Espejo-Arce X, Hidalgo MM, Hidlago-Regina C, Teatin-Juliato C, Petta C (2006b) A cross-sectional study of the forearm bone density of long-term users of levonorgestrel-releasing intrauterine system. Hum Reprod 21(5):1316–1319

    CAS  PubMed  Google Scholar 

  • Bahamondes MV, Monteiro I, Castro S, Espejo-Arce X, Bahamondes L (2010) Prospective study of the forearm bone mineral density of long-term users of the levonorgestrel-releasing intrauterine system. Hum Reprod 25(5):1158–1164

    CAS  PubMed  Google Scholar 

  • Baram I, Weinstein A, Trussell J (2014) The IUB, a newly invented IUD: a brief report. Contraception 89(2):139–141

    PubMed  Google Scholar 

  • Bastianelli C, Farris M, Benagiano G (2011) Use of the levonorgestrel-releasing intrauterine system, quality of life and sexuality. Experience in an Italian family planning center. Contraception 84(4):402–408

    PubMed  Google Scholar 

  • Bayer PLC (2013) Mirena: summary of product characteristics. http://www.medicines.org.uk/

  • Bayer PLC (2014) Jaydess 13.5 mg intrauterine delivery system: summary of product characteristics. Bayer PLC, London

    Google Scholar 

  • Beerthuizen R, van Beek A, Massai R, Makarainen L, Hout J, Bennink HC (2000) Bone mineral density during long-term use of the progestagen contraceptive implant Implanon compared to a non-hormonal method of contraception. Hum Reprod 15(1):118–122

    CAS  PubMed  Google Scholar 

  • Beining RM, Dennis LK, Smith EM, Dokras A (2008) Meta-analysis of intrauterine device use and risk of endometrial cancer. Ann Epidemiol 18(6):492–499

    PubMed  Google Scholar 

  • Belfield T (2005) Contraception: users’ perspectives and determinants of choice. In: Glasier A, Wellings K, Critchley H (eds) Contraception and contraceptive use. RCOG Press, London

    Google Scholar 

  • Bensouda-Grimaldi L, Jonville-Bera AP, Beau-Salinas F, Llabres S, Autret-Leca E, Le Reseau Des Centres Regionaux De P (2005) Insertion problems. removal problems and contraception failures with Implanon. Gynecol Obstet Fertil 33:986–990

    CAS  PubMed  Google Scholar 

  • Bentley J (2013) Experience and removal of damaged implants. J Fam Plann Reprod Health Care 39(3):233

    PubMed  Google Scholar 

  • Biswas A, Leong WP, Ratnam SS, Viegas OA (1996) Menstrual bleeding patterns in Norplant-2 implant users. Contraception 54(2):91–95

    CAS  PubMed  Google Scholar 

  • Bounds W, Guillebaud J (2002) Observational series on women using the contraceptive Mirena concurrently with anti-epileptic and other enzyme-inducing drugs. J Fam Plann Reprod Health Care 28(2):78–80

    PubMed  Google Scholar 

  • Brache V, Faundes A, Alvarez F, Cochon L (2002) Nonmenstrual adverse events during use of implantable contraceptives for women: data from clinical trials. Contraception 65:63–74

    CAS  PubMed  Google Scholar 

  • Bragg TW, Jose RM, Bland JW, Matthews RN, Srivastava S (2006) Implantable contraceptive devices: primum non nocere. J Fam Plann Reprod Health Care 32(3):190–192

    PubMed  Google Scholar 

  • Brahmi D, Steenland MW, Renner RM, Gaffield ME, Curtis KM (2012) Pregnancy outcomes with an IUD in situ: a systematic review. Contraception 85(2):131–139

    PubMed  Google Scholar 

  • Brown M, Britton J (2012) Neuropathy associated with etonogestrel implant insertion. Contraception 86(5):591–593

    PubMed  Google Scholar 

  • Buckshee K, Chatterjee P, Dhall GI, Hazra MN, Kodkany BS, Lalitha K et al (1995) Return of fertility following discontinuation of Norplant-II subdermal implants. ICMR Task Force on Hormonal Contraception. Contraception 51(4):237–242

    CAS  PubMed  Google Scholar 

  • Buhling KJ, Zite NB, Lotke P, Black K (2014) Worldwide use of intrauterine contraception: a review. Contraception 89(3):162–173

    PubMed  Google Scholar 

  • Caliskan E, Öztürk N, Dilbaz BÖ, Dilbaz S (2003) Analysis of risk factors associated with uterine perforation by intrauterine devices. Eur J Contracept Reprod Health Care 8(150):155

    Google Scholar 

  • Carr S, Espey E (2013) Intrauterine devices and pelvic inflammatory disease among adolescents. [Review]. J Adolescent Health 52(4:Suppl):S22–8

    Google Scholar 

  • Castellsague X, Diaz M, Vaccarella S, de Sanjosé SS, Munoz N, Herrero R et al (2011) Intrauterine device use, cervical infection with human papillomavirus, and risk of cervical cancer: a pooled analysis of 26 epidemiological studies. Lancet Oncol 12(11):1023–1031

    PubMed  Google Scholar 

  • Centre for Disease Control (2010) U.S. medical eligibility criteria for contraceptive use 2010. Morb Mortal Wkly Rep 59(RR4):1–85

    Google Scholar 

  • Chadha-Gupta A, Moss A (2007) Fat atrophy at the site of a subdermal contraceptive implant. J Fam Plann Reprod Health Care 33(2):123–124

    PubMed  Google Scholar 

  • Chakhtoura Z, Canonico M, Gompel A, Scarabin P-Y, Plu-Bureau G (2011) Progestogen-only contraceptives and the risk of acute myocardial infarction: a meta-analysis. J Clin Endocrinol Metab 96(4):1169–1174

    CAS  PubMed  Google Scholar 

  • Chaudry F (2013) Adverse reaction to Nexplanon. J Fam Plann Reprod Health 39:231–232

    Google Scholar 

  • Cheung VY (2010) A 10-year experience in removing Chinese intrauterine devices. Int J Gynaecol Obstet 109(3):219–222

    PubMed  Google Scholar 

  • Chi IC (1991) An evaluation of the levonorgestrel-releasing IUD: its advantages and disadvantages when compared to the copper-releasing IUDs. Contraception 44(6):573–588

    CAS  PubMed  Google Scholar 

  • Chin J, Konje JC, Hickey M (2009) Levonorgestrel intrauterine system for endometrial protection in women with breast cancer on adjuvant tamoxifen. Cochrane Database Syst Rev 4, CD007245. doi:10.1002/14651858, CD007245.pub2

    PubMed  Google Scholar 

  • Cho EE, Fernando D (2013) Fatal streptococcal toxic shock syndrome from an intrauterine device. J Emerg Med 44(4):777–780

    PubMed  Google Scholar 

  • Cho S, Nam A, Kim H, Chay D, Park K, Cho DJ et al (2008) Clinical effects of the levonorgestrel-releasing intrauterine device in patients with adenomyosis. Am J Obstet Gynecol 198:e1–e7

    Google Scholar 

  • Ciangura C, Corigliano N, Basdevant A, Mouly S, Decleves XS, Touraine P et al (2012) Etonogestrel concentrations in morbidly obese women following Roux-en-Y gastric bypass surgery: three case reports. Contraception 84:649–651

    Google Scholar 

  • Cole JA, Norman H, Doherty M, Walker AM (2007) Venous thromboembolism, myocardial infarction, and stroke among transdermal contraceptive system users. Am J Obstet Gynecol 109(2):339–346

    Google Scholar 

  • Cox M, Tripp J, Blacksell S (2002) Clinical performance of the levonorgestrel intrauterine system in routine use by the UK family planning and reproductive health research network: 5-year report. J Fam Plann Reprod Health Care 28(2):73–77

    PubMed  Google Scholar 

  • Crosignani PG, Vercellini P, Mosconi P, Oldani S, Cortesi I, De Giorgi O (1997) Levonorgestrel-releasing intrauterine device versus hysteroscopic endometrial resection in the treatment of dysfunctional uterine bleeding. Obstet Gynecol 90:257–263

    CAS  PubMed  Google Scholar 

  • Croxatto HB (2000) Clinical profile of Implanon: a single-rod etonogestrel contraceptive implant. Eur J Contraception Reprod Health Care 5:21–28

    CAS  Google Scholar 

  • Croxatto HB (2002) Mechanisms that explain the contraceptive action of progestin implants for women. Contraception 65:21–27

    CAS  PubMed  Google Scholar 

  • Croxatto HB, Urbancsek J, Massai R, Coelingh Bennik H, van Beek A, The Implanon Study Group (1999) A multicentre efficacy and safety study of the single contraceptive implant Implanon. Hum Reprod 14(4):976–981

    CAS  PubMed  Google Scholar 

  • Curtis KM, Marchbanks PA, Peterson HB (2007) Neoplasia with use of intrauterine devices. Contraception 75(6):s60–s69

    PubMed  Google Scholar 

  • Dal’Ava N, Bahamondes L, Bahamondes MV, de Oliveira SA, Monteiro I (2012) Body weight and composition in users of levonorgestrel-releasing intrauterine system. Contraception 86(4):350–353

    PubMed  Google Scholar 

  • Danish Medicines Agency (2011) Danish Pharmacovigilance update. 2#3, http://sundhedsstyrelsen.dk/en/medicines/safety/side-effects/danish-pharmacovigilance-update/~/media/E63BAC40C0CB49ADABD8B473CB7B09F6.ashx

  • Darney P, Patel A, Rosen K, Shapiro LS, Kaunitz AM (2009) Safety and efficacy of a single-rod etonogestrel implant (Implanon): results from 11 clinical trials. Fertil Steril 91(5):1646–1653

    PubMed  Google Scholar 

  • Datey S, Gaur LN, Saxena BN (1995) Vaginal bleeding patterns of women using different contraceptive methods (implants, injectables, IUDs, oral pills) an Indian experience. Contraception 51:155–165

    CAS  PubMed  Google Scholar 

  • Deans EI, Grimes DA (2009) Intrauterine devices for adolescents: a systematic review. [Review] [43 refs]. Contraception 79(6):418–423

    PubMed  Google Scholar 

  • Dekker S (2011) Patient safety: a human factors approach. CRC Press, Boca Raton

    Google Scholar 

  • Division of Human Resource Development Research (1993) Phase III clinical trial with Norplant II (two covered rods): report on five years of use. Contraception 48(2):120–132

    Google Scholar 

  • Di Carlo C, Sansone A, De Rosa N, Gargano V, Tommaselli GA, Nappi C et al (2014) Impact of an implantable steroid contraceptive (etonogestrel-releasing implant) on quality of life and sexual function: a preliminary study. Gynecol Endocrinol 30(1):53–56

    CAS  PubMed  Google Scholar 

  • Diaz S, Pavez M, Cardenas H, Croxatto HB (1987) Recovery of fertility and outcome of planned pregnancies after the removal of NORPLANT subdermal implants or copper-T IUDs. Contraception 35(6):569–579

    CAS  PubMed  Google Scholar 

  • Diaz J, Faudes A, Diaz M, Marchi N (1993) Evaluation of the clinical performance of a levonorgestrel-releasing IUD, up to seven years of use, in Campinas, Brazil. Contraception 47(2):169–175

    CAS  PubMed  Google Scholar 

  • Dinger J, Bardenheuer K, Minh TD (2011) Levonorgestrel-releasing and copper intrauterine devices and risk of breast cancer. Contraception 83:211–217

    CAS  PubMed  Google Scholar 

  • Doll H, Vessey M, Painter R (2001) Return of fertility in nulliparous women after discontinuation of the intrauterine device: comparison with women discontinuing other methods of contraception. Br J Obstet Gynaecol 108:304–314

    CAS  Google Scholar 

  • Dore DD, Norman H, Loughlin J, Seeger JD (2010) Extended case-control study results on thromboembolic outcomes among transdermal contraceptive users. Contraception 81:408–413

    CAS  PubMed  Google Scholar 

  • Doshi J (2011) Bent Implanon. J Fam Plann Reprod Health Care 37(2):126

    PubMed  Google Scholar 

  • Dunson TR, Amatya RN, Krueger SL (1995) Complications and risk factors associated with the removal of Norplant implants. Obstet Gynecol 85(4):543–548

    CAS  PubMed  Google Scholar 

  • Enzlin P, Weyers S, Janssens D, Poppe W, Eelen C, Pazmany E et al (2012) Sexual functioning in women using levonorgestrel-releasing intrauterine systems as compared to copper intrauterine devices. J Sex Med 9(4):1065–1073

    PubMed  Google Scholar 

  • Ernst U (2004) The case of the missing implant: the importance of adhering to insertion guidelines. Eur J Contracept Reprod Health Care 1–6, Poster Abstract 180

    Google Scholar 

  • European Medicines Agency (2014) Benefits of combined hormonal contraceptives (CHCs) continue to outweigh risks. Product information updated to help women make informed decisions about their choice of contraception. http://www.ema.europa.eu/ema/index.jsp?curl = pages/medicines/human/referrals/Combined_hormonal_contraceptives/human_referral_prac_000016.jsp&mid = WC0b01ac05805c516f

  • European Society for Human Reproduction and Embryology (2013) Guideline on the management of women with endometriosis. http://www.eshre.eu/Guidelines-and-Legal/Guidelines/Endometriosis-guideline.aspx

  • Faculty of Sexual and Reproductive Healthcare (2008) Progestogen-only injectables. http://www.fsrh.org/admin/uploads/CEUGuidanceProgestogenOnlyInjectables09.pdf

  • Faculty of Sexual and Reproductive Healthcare (2009a) UK medical eligibility criteria for contraceptive use. (UKMEC 2009). http://www.fsrh.org/admin/uploads/UKMEC2009.pdf

  • Faculty of Sexual and Reproductive Healthcare (2009b) The management of unscheduled bleeding in women using hormonal contraception

    Google Scholar 

  • Faculty of Sexual and Reproductive Healthcare (2010) Contraception for women aged over 40 years. http://www.fsrh.org/admin/uploads/ContraceptionOver40July10.pdf

  • Faculty of Sexual and Reproductive Healthcare (2011a) Drug interactions with hormonal contraception. http://www.fsrh.org/pdfs/CEUGuidanceDrugInteractionsHormonal.pdf

  • Faculty of Sexual and Reproductive Healthcare (2011b) Combined hormonal contraception. http://www.fsrh.org/pdfs/CEUGuidanceCombinedHormonalContraception.pdf

  • Faculty of Sexual and Reproductive Healthcare (2014) Progestogen-only implants. http://www.fsrh.org/pdfs/CEUGuidanceProgestogenOnlyImplants.pdf

  • Faculty of Sexual and Reproductive Healthcare (2015, in press) Intrauterine Contraception. www.fsrh.org

  • Farley TNM, Rowe PJ, Meirik O, Rosenberg MJ, Chen JH (1992) Intrauterine devices and pelvic inflammatory disease: an international perspective. Lancet 339:785–788

    CAS  PubMed  Google Scholar 

  • Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M (1997) Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril 68(3):426–429

    CAS  PubMed  Google Scholar 

  • Flores JB, Balderas ML, Bonilla MC, Vázquez-Estrado L (2005) Clinical experience and acceptability of the etonogestrel subdermal contraceptive implant. Int J Gynecol Obstet 90:228–233

    CAS  Google Scholar 

  • Fraser IS (2006) The challenges of location and removal of Implanon contraceptive implants. J Fam Plann Reprod Health Care 32(3):151–152

    PubMed  Google Scholar 

  • French RS, Cowan FM, Mansour DJA, Morris S, Procter T, Hughes D et al (2000) Implantable contraceptives (subdermal implants and hormonally impregnated intrauterine systems) versus other forms of reversible contraceptives: two systematic reviews to assess relative effectiveness, acceptability, tolerability and cost-effectiveness. Health Technol Assess 4(7):1–107

    Google Scholar 

  • French R, Sorhaindo AM, Van Vliet HAAM, Mansour DD, Robinson AA, Logan S, Helmerhorst FM, Guillebaud J, Cowan FM (2004) Progestogen-releasing intrauterine systems versus other forms of reversible contraceptives for contraception. Cochrane Database Syst Rev 3:CD001776. doi: 10.1002/14651858.CD001776.pub2

  • Funk S, Miller MM, Mishell DR, Archer DF, Poindexter A, Schmidt J et al (2005) Safety and efficacy of Implanon, a single-rod implantable contraceptive containing etonogestrel. Contraception 71:319–326

    CAS  PubMed  Google Scholar 

  • Gallos ID, Shehmar M, Thangaratinam S, Papapostolou TK, Coomarasamy A, Gupta JK (2010) Oral progestogens vs levonorgestrel-releasing intrauterine system for endometrial hyperplasia: a systematic review and metaanalysis. [Review]. Am J Obstet Gynecol 203(6):547.e1-10

    PubMed  Google Scholar 

  • Gallos ID, Krishan P, Shehmar M, Ganesan R, Gupta JK (2013) LNG-IUS versus oral progestogen treatment for endometrial hyperplasia: a long-term comparative cohort study. Hum Reprod 28(11):2966–2971

    CAS  PubMed  Google Scholar 

  • Ganz ML, Shah D, Gidwani R, Filonenko A, Su W, Pocoski J et al (2013) The cost-effectiveness of the levonorgestrel-releasing intrauterine system for the treatment of idiopathic heavy menstrual bleeding in the United States. Value Health 16(2):325–333

    PubMed  Google Scholar 

  • Gbolade BA (2010) Failure of Implanon® on antituberculous therapy. Open Access J Contraception 1:103–105

    Google Scholar 

  • Gemzell-Danielsson K, Schellschmidt I, Apter D (2012) A randomized, phase II study describing the efficacy, bleeding profile, and safety of two low-dose levonorgestrel-releasing intrauterine contraceptive systems and Mirena. Fertil Steril 97(3):616–622

    CAS  PubMed  Google Scholar 

  • Gillies R, Scougall P, Nicklin S (2011) Etonogestrel implants – case studies of median nerve injury following removal. Aust Fam Physician 40(10):799–800

    PubMed  Google Scholar 

  • Gisser J, Fields MC, Pick N, Moses AE, Srugo I (2002) Invasive group A streptococcus associated with an intrauterine device and oral sex. Sex Transm Dis 29(8):483–485

    PubMed  Google Scholar 

  • Glasier A, Scorer J, Bigrigg A (2008) Attitudes of women in Scotland to contraception: a qualitative study to explore the acceptability of long-acting methods. J Fam Plann Reprod Health Care 34(4):213–217

    PubMed  Google Scholar 

  • Godfrey EM, Folger SG, Jeng G, Jamieson DJ, Curtis KM (2013) Treatment of bleeding irregularities in women with copper-containing IUDs: a systematic review. [Review]. Contraception 87(5):549–566

    CAS  PubMed  Google Scholar 

  • Goldstuck ND, Steyn PS (2013) Intrauterine contraception after cesarean section and during lactation: a systematic review. Int J Womens Health 5(1):811–818

    PubMed Central  PubMed  Google Scholar 

  • Graesslin O, Korver T (2008) The contraceptive efficacy of Implanon: a review of clinical trials and marketing experience. Eur J Contracept Reprod Health Care 13(1):4–12

    CAS  PubMed  Google Scholar 

  • Grimes D (2000) Intrauterine device and upper-genital tract infection. Lancet 356(9234):1013–1019

    CAS  PubMed  Google Scholar 

  • Grimes DA, Lopez LM, Schulz KF, van Vliet HAAM, Stanwood NL (2010a) Immediate post-partum insertion of intrauterine devices. Cochrane Database Syst Rev 5, CD003036

    PubMed  Google Scholar 

  • Grimes DA, Lopex LM, Schulz KF, Stanwood NL (2010b) Immediate postabortal insertion of intrauterine devices (Cochrane Review). Cochrane Database Syst Rev (6):CD001777

    Google Scholar 

  • Grunloh DS, Casner T, Secura GM, Peipert JF, Madden T (2013) Characteristics associated with discontinuation of long-acting reversible contraception within the first 6 months of use. Obstet Gynecol 122(6):1214–1221

    CAS  PubMed  Google Scholar 

  • Gwinnell E (2007) Expulsion of Implanon. J Fam Plann Reprod Health Care 33(3):211

    PubMed  Google Scholar 

  • Harrison-Woolrych M, Hill R (2005) Unintended pregnancies with the etonogestrel implant (Implanon): a case series from postmarketing experience in Australia. Contraception 71:306–308

    PubMed  Google Scholar 

  • Harrison-Woolrych M, Ashton J, Coulter D (2003) Uterine perforation on intrauterine device insertion: is the incidence higher than previously reported? Contraception 67:53–56

    PubMed  Google Scholar 

  • Harvey C, Seib C, Lucke J (2009) Continuation rates and reasons for removal among Implanon users accessing two family planning clinics in Queensland, Australia. Contraception 80:527–532

    PubMed  Google Scholar 

  • Haukkamaa M (1986) Contraception by Norplant subdermal capsules is not reliable in epileptic patients on anticonvulsant treatment. Contraception 33(6):559–565

    CAS  PubMed  Google Scholar 

  • Heinemann K, Reed S, Moehner S (2013a) Ectopic pregnancies under IUD use: interim results from the EURAS-IUD study. Pharmacoepidemiol Drug Saf 22(1):430

    Google Scholar 

  • Heinemann K, Reed S, Moehner S (2013b) Breastfeeding as a risk factor for uterine perforation during IUD insertion: interim results from the euras-IUD study. Pharmacoepidemiology and drug safety conference. In: 29th international conference on pharmacoepidemiology and therapeutic risk management, Montreal, conference start: 2013-08-25 conference end: 2013-08-28 conference publication: (var pagings) 22(pp 12):October

    Google Scholar 

  • Heinemann K, Westhoff CL, Grimes DA, Moehner S (2014) Intrauterine devices and the risk of uterine perforations: final results from the EURAS-IUD study. Obstet Gynecol 123(1):3S

    PubMed  Google Scholar 

  • Hidalgo MM, Lisondo C, Juliato CT, Espejo-A X, Monterio I, Bahamondes L (2006) Ovarian cysts in users of Implanon and Jadelle subdermal contraceptive implants. Contraception 73:532–536

    CAS  PubMed  Google Scholar 

  • Hov G, Skjeldestad FE, Hilstad T (2007) Use of IUD and subsequent fertility- follow- up after participation in a randomized clinical trial. Contraception 75:88–92

    PubMed  Google Scholar 

  • Hubacher D, Grimes DA (2002) Noncontraceptive health benefits of intrauterine devices: a systematic review. Obstet Gynecol Surv 57(2):120–128

    PubMed  Google Scholar 

  • Hubacher D, Chen PL, Park S (2009) Side effects from the copper IUD: do they decrease over time? Contraception 79(5):356–362

    CAS  PubMed Central  PubMed  Google Scholar 

  • Hubacher D, Grimes DA, Gemzell-Danielsson K (2013) Pitfalls of research linking the intrauterine device to pelvic inflammatory disease. Obstet Gynecol 121(5):1091–1098

    PubMed  Google Scholar 

  • Hueston WJ, Locke KT (1995) Norplant neuropathy: peripheral neurologic symptoms associated with subdermal contraceptive implants. [Review] [8 refs]. J Fam Pract 40(2):184–186

    CAS  PubMed  Google Scholar 

  • Inki P, Hurskainen R, Palo P, Ekholm E, Grenman S, Kivelä A et al (2002) Comparison of ovarian cyst formation in women using the levonorgestrel-releasing intrauterine system vs. hysterectomy. Ultrasound Obstet Gynecol 20:381–385

    CAS  PubMed  Google Scholar 

  • International Collaborative Post-Marketing Surveillance of Norplant (2006) Post-marketing surveillance of Norplant contraceptive implants: I. contraceptive efficacy and reproductive health. Contraception 63(4):167–186

    Google Scholar 

  • Ismail H, Mansour D, Singh M (2006) Migration of Implanon. J Fam Plann Reprod Health Care 32(3):157–159

    PubMed  Google Scholar 

  • Janssen Pharmaceuticals I (2014) OrthoEvra. http://www.orthoevra.com/fullprescribeinfo.html. Available from http://www.orthoevra.com/fullprescribeinfo.html

  • Janssen-Cilag Ltd (2014) Evra transdermal patch. http://www.medicines.org.uk/emc/

  • Jick SS, Kaye JA, Russmann S, Jick H (2006) Risk of nonfatal venous thromboembolism in women using a contraceptive transdermal patch and oral contraceptives containing norgestimate and 35ug of ethinyl estradiol. Contraception 73:223–228

    CAS  PubMed  Google Scholar 

  • Jick S, Kaye JA, Li L, Jick H (2007) Further results on the risk of nonfatal venous thromboembolism in users of the contraceptive transdermal patch compared to users of oral contraceptive containing norgestimate and 35ug of ethinyl estradiol. Contraception 76:4–7

    CAS  PubMed  Google Scholar 

  • Jick SS, Hagberg KW, Hernandez RK, Kaye JA (2010) Postmarketing study of ORTHO EVRA and levonorgestrel oral contraceptive containing hormonal contraceptives with 30mcg of ethinylestradiol in relation to nonfatal venous thromboembolism. Contraception 81:16–21

    CAS  PubMed  Google Scholar 

  • Kaislasuo J, Suhonen S, Gissler M, Lahteenmaki P, Heikinheimo O (2012) Intrauterine contraception: incidence and factors associated with uterine perforation–a population-based study. Hum Reprod 27(9):2658–2663

    PubMed  Google Scholar 

  • Kaislasuo J, Suhonen S, Gissler M, Lahteenmaki P, Heikinheimo O (2013) Uterine perforation caused by intrauterine devices: clinical course and treatment. Hum Reprod 28(6):1546–1551

    PubMed  Google Scholar 

  • Kapp N, Curtis KM (2009) Intrauterine device insertion during the postpartum period: a systematic review. Contraception 80(4):327–336

    PubMed  Google Scholar 

  • Kelekci S, Kelekci KH, Yilmaz B (2012) Effects of levonorgestrel-releasing intrauterine system and T380A intrauterine copper device on dysmenorrhea and days of bleeding in women with and without adenomyosis. Contraception 86(5):458–463

    CAS  PubMed  Google Scholar 

  • Klavon SL, Grubb GS (1990) Insertion site complications during the first year of NORPLANT use. Contraception 41(1):27–37

    CAS  PubMed  Google Scholar 

  • Kulier R, O’Brien P, Helmerhorst FM, Usher-Patel M, d’Arcangues C (2007) Copper containing, framed intra-uterine devices for contraception. Cochrane Database Syst Rev 4:CD005347. doi: 10.1002/14651858.CD005347.pub3

  • Lakha F, Glasier A (2006) Continuation rates of Implanon in the UK: data from an observational study in a clinical setting. Contraception 74:287–289

    PubMed  Google Scholar 

  • Lakhi N, Govind A (2010) Implanon failure in patients on antiretroviral medication: the importance of disclosure. J Fam Plann Reprod Health Care 36(3):181–182

    PubMed  Google Scholar 

  • Lethaby AE, Cooke I, Rees M (2005) Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding (Review). Cochrane Library 3, CD002126. doi:10.1002/14651858, CD002126.pub2

    Google Scholar 

  • Li RHW, Lo SST, Teh DKG, Tong N-C, Tsui MHY, Cheung K-B et al (2004) Impact of common contraceptive methods on quality of life and sexual function in Hong Kong Chinese women. Contraception 79:474–482

    Google Scholar 

  • Lidegaard O, Nielson L, Skovlund CW, Lokkegaard E (2012a) Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10. BMJ 344:e2990

    PubMed Central  PubMed  Google Scholar 

  • Lidegaard O, Lokkegaard E, Jensen A, Skovlund CW, Keiding N (2012b) Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 366(24):2257–2266

    CAS  PubMed  Google Scholar 

  • Lindh I, Milsom I (2013) The influence of intrauterine contraception on the prevalence and severity of dysmenorrhea: a longitudinal population study. Hum Reprod 28(7):1953–1960

    CAS  PubMed  Google Scholar 

  • Lindsay P (2010) Resolution of localised lipoatrophy at the site of Implanon insertion. J Fam Plann Reprod Health Care 36(2):107

    PubMed  Google Scholar 

  • Lockhat FB, Emembolu JO, Konje JC (2005) The efficacy, side-effects and continuation rates in women with symptomatic endometriosis undergoing treatment with an intra-uterine administered progestogen (levonorgestrel): a 3 year follow-up. Hum Reprod 20(3):789–793

    CAS  PubMed  Google Scholar 

  • Lopez LM, Chen M, Mullins S, Curtis KM, Helmerhorst FM (2012) Steroidal contraceptives and bone fractures in women: evidence from observational studies. Cochrane Database Syst Rev 8, CD009849. doi:10.1002/14651858, CD009849.pub2

    PubMed  Google Scholar 

  • Lopez LM, Edelman A, Chen M, Otterness C, Trussell J, Helmerhorst FM (2013a) Progestin-only contraceptives: effects on weight. Cochrane Database Syst Rev 7, CD008815. doi:10.1002/14651858, CD008815.pub3

    PubMed  Google Scholar 

  • Lopez LM, Grimes DA, Gallo MF, Stockton LL, Schulz KF (2013b) Skin patch and vaginal ring versus combined oral contraceptives for contraception. Cochrane Database of Syst Rev (4):CD003552

    Google Scholar 

  • Lowe RF, Prata N (2013) Hemoglobin and serum ferritin levels in women using copper-releasing or levonorgestrel-releasing intrauterine devices: a systematic review. [Review]. Contraception 87(4):486–496

    CAS  PubMed  Google Scholar 

  • Luo L, Luo B, Zheng Y, Zhang H, LI J, Sidell N (2013) Levonorgestrel-releasing intrauterine system for atypical endometrial hyperplasia. Cochrane Database Syst Rev 6, CD009458. doi:10.1002/14651858, CD009458.pub2

    PubMed  Google Scholar 

  • Lyytinen HK, Dyba T, Ylikorkala O, Pukkala EI (2010) A case-control study on hormone therapy as a risk factor for breast cancer in Finland: Intrauterine system carries a risk as well. Int J Cancer 126(2):483–489

    CAS  PubMed  Google Scholar 

  • Mansour D (2013) Comment on ‘Adverse reaction to Nexplanon’. J Fam Plann Reprod Health 39:232–233

    Google Scholar 

  • Mansour D, Korver T, Marintcheva-Petrova M, Fraser IS (2008a) The effects of Implanon on menstrual bleeding patterns. Eur J Contracept Reprod Health Care 13(Supp 1):13–28

    CAS  PubMed  Google Scholar 

  • Mansour D, Fraser IS, Walling M, Glenn D, Graesslin O, Egarter C (2008b) Methods of accurate localisation of non-palpable subdermal contraceptive implants. J Fam Plann Reprod Health Care 34(1):9–12

    PubMed  Google Scholar 

  • Mansour D, Mommers E, Teede H, Sollie-Eriksen B, Graesslin O, Ahrendt HJ et al (2010) Clinician satisfaction and insertion characteristics of a new applicator to insert radiopaque Implanon: an open-label, noncontrolled, multicenter trial. Contraception 82(3):243–249

    PubMed  Google Scholar 

  • Mansour D, Gemzell-Danielsson K, Inki P, Jensen JT (2011) Fertility after discontinuation of contraception: a comprehensive review of the literature. Contraception 84(5):465–477

    CAS  PubMed  Google Scholar 

  • Mantha S, Karp R, Raghavan V, Terrin N, Bauer KA, Zwicker JI (2012) Assessing the risk of venous thromboembolic events in women taking progestin-only contraception: a meta-analysis. BMJ 345:e4944

    CAS  PubMed Central  PubMed  Google Scholar 

  • Martin-Loeches M, OrtÍ RM, Monfort M, Ortega E, Rius J (2003) A comparative analysis of the modification of sexual desire of users of oral hormonal contraceptives and intrauterine contraceptive devices. Eur J Contracept Reprod Health Care 8:129–134

    CAS  PubMed  Google Scholar 

  • Mascarenhas L (1998) Insertion and removal of Implanon. Contraception 58(6(suppl 1)):79S–83S

    CAS  PubMed  Google Scholar 

  • Matiluko AA, Soundararjan L, Hogston P (2007) Early contraceptive failure of Implanon in an HIV-seropositive patient on triple antiretroviral therapy with zidovundine, lamivudine and efavirenz. J Fam Plann Reprod Health Care 33(4):277–278

    PubMed  Google Scholar 

  • Matteson KA, Rahn DD, Wheeler TL, Casiano E, Siddiqui NY, Harvie HS et al (2013) Nonsurgical management of heavy menstrual bleeding: a systematic review. [Review]. Obstet Gynecol 121(3):632–643

    PubMed  Google Scholar 

  • McCarty EJ, Keane H, Quinn K, Quah S (2011) Implanon failure in an HIV-positive woman on antiretroviral therapy resulting in two ectopic pregnancies. Int J STD AIDS 22(7):413–414

    CAS  PubMed  Google Scholar 

  • MDU (2011) Advice to GPs inserting contraceptive implants. http://www.themdu.com/guidance-and-advice/latest-updates-and-advice/advice-to-gps-inserting-contraceptive-implants

  • Medicines and Healthcare Products Regulatory Agency (2013) Drug analysis print (DAP)- etonogestrel. http://www.mhra.gov.uk/

  • Medicines and Healthcare Products Regulatory Agency (2014) St John’s wort: interaction with hormonal contraceptives, including implants – reduced contraceptive effect. http://www.mhra.gov.uk/Safetyinformation/DrugSafetyUpdate/CON392869

  • Merck Sharp and Dohme Limited (2013) Nexplanon: summary of product characteristics. http://www.medicines.org.uk/emc/

  • Merck Sharp and Dohme Limited (2014) Nuvaring. http://www.medicines.org.uk/emc/medicine/21419/SPC/Nuvaring

  • Mohlala B, Falowo F (2010) Resolution of localised lipoatrophy at the site of Implanon© insertion- Reply. J Fam Plann Reprod Health Care 36(2):107

    Google Scholar 

  • Monteiro-Dantas C, Espejo-Arce X, Lui-Filho J, Fernandes A, Monteiro I, Bahamondes L (2007) A three-year longitudinal evaluation of the forearm bone density of users of etonogestrel- and levonorgestrel-releasing contraceptive implants. Reprod Health 4:353–360

    Google Scholar 

  • Mornar S, Lingtak-Neander C, Mistretta S, Neustadt A, Martins S, Gilliam M (2012) Pharmacokinetics of the etonogestrel contraceptive implant in obese women. Am J Obstet Gynecol 207(2):e1–e6

    PubMed  Google Scholar 

  • Mourtialon P, Tixier H, Loffroy R, Maillart JC, Calmelet P, Dellinger P et al (2008) Vascular complication after insertion of a subcutaneous contraceptive implant. Acta Obstet Gynecol Scand 87(11):1256–1258

    PubMed  Google Scholar 

  • Nath A, Sitruk-Ware R (2010) Progesterone vaginal ring for contraceptive use during lactation. [Review]. Contraception 82(5):428–434

    CAS  PubMed  Google Scholar 

  • National Institute for Health and Care Excellence (NICE) (2005) Long-acting reversible contraception: the effective and appropriate use of long-acting reversible contraception, NICE clinical guideline 30. NICE, London. http://www.nice.org.uk/pdf/CG030fullguideline.pdf

  • National Institute for Health and Care Excellence (2007) Heavy menstrual bleeding, NICE clinical guideline 44. NICE, London

    Google Scholar 

  • National Institute for Health and Care Excellence (NICE) (2014) Addendum to clinical guideline 30, long-acting reversible contraception. NICE, London

    Google Scholar 

  • Nault AM, Peipert JF, Zhao Q, Madden T, Secura GM (2013) Validity of perceived weight gain in women using long-acting reversible contraception and depot medroxyprogesterone acetate. Am J Obstet Gynecol 208(1):e1–e8

    PubMed  Google Scholar 

  • Navani M, Robinson C (2005) Clinical challenge with Implanon removal: a case report. J Fam Plann Reprod Health Care 31(2):161–162

    PubMed  Google Scholar 

  • Nelson A, Apter D, Hauck B, Schmelter T, Rybowski S, Rosen K et al (2013) Two low-dose levonorgestrel intrauterine contraceptive systems: a randomized controlled trial. Obstet Gynecol 122(6):1205–1213

    CAS  PubMed  Google Scholar 

  • New Zealand Consumer Medicine Information (2013a) Jadelle. http://www.medsafe.govt.nz/consumers/cmi/j/jadelle.pdf

  • New Zealand Medicines and Medical Devices Safety Authority (2013b) Removal difficulties with Jadelle and Implanon. Prescriber update 34(3):27–28

    Google Scholar 

  • Nilsson CG, Luukkainen T, Diaz J, Allonen H (1982) Clinical performance of a new levonorgestrel-releasing intra-uterine device a randomized comparison with a Nova-T-Copper device. Contraception 25(4):345–356

    CAS  PubMed  Google Scholar 

  • Nilsson CG, Allonen H, Diaz J, Luukkainen T (1983) Two years’ experience with two levonorgestrel-releasing intrauterine devices and one copper-releasing intrauterine device: a randomized comparative performance study. Fertil Steril 39(2):187–192

    CAS  PubMed  Google Scholar 

  • O’Brien PA, Marfleet C (2005) Frameless versus classical intrauterine device for contraception. Cochrane Database Syst Rev (1):CD003282. doi:10.1002/14651858. CD003282.pub2

  • Ortiz ME, Croxatto HB (2007) Copper-T intrauterine device and levonorgestrel intrauterine system: biological bases of their mechanism of action. [Review] [76 refs]. Contraception 75(6 Suppl):S16-S30

    Google Scholar 

  • Ory HW (1981) Ectopic pregnancy and intrauterine contraceptive devices: new perspectives. The women’s health study. Obstet Gynecol 57(2):137–144

    CAS  PubMed  Google Scholar 

  • Osman N, Dinh A, Dubert T, Goubier JN (2005) A new cause for iatrogenic lesion of the ulnar nerve at the arm: contraceptive hormonal implant. Report of two cases [French]. Chirurgie de la Main 24(3–4):181–183

    Google Scholar 

  • Ozdegirmenci O, Kayikcioglu F, Akgul MA, Kaplan M, Karcaaltincaba M, Haberal A et al (2011) Comparison of levonorgestrel intrauterine system versus hysterectomy on efficacy and quality of life in patients with adenomyosis. Fertil Steril 95(2):497–502

    CAS  PubMed  Google Scholar 

  • Patni S, Ebden P, Kevelighan E, Bibby J (2006) Ectopic pregnancy with Implanon. J Fam Plann Reprod Health Care 32(2):115

    PubMed  Google Scholar 

  • Penney GC, Brechin S, Glasier AF (2006) Family planning masterclass: evidence-based answers to 1000 questions. RCOG Press, London

    Google Scholar 

  • Petta CA, Ferriani RA, Abaro MS, Hassan D, Rosa e Silva JC, Podgaec S et al (2005) Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 20:1993–1998

    CAS  PubMed  Google Scholar 

  • Pickard S, Bacon L (2002) Persistent vaginal bleeding in a patient with a broken Implanon. J Fam Plann Reprod Health Care 28(4):207–208

    PubMed  Google Scholar 

  • Pongsatha S, Ekmahachai M, Suntornlimsiri N, Morakote N, Chaovisitsaree S (2010) Bone mineral density in women using the subdermal contraceptive implant Implanon for at least 2 years. Int J Gynecol Obstet 109:223–225

    CAS  Google Scholar 

  • Ponpuckdee J, Taneepanichskul S (2005) The effects of Implanon in the symptomatic treatment of endometriosis. J Med Assoc Thai 88(2):s7–s10

    PubMed  Google Scholar 

  • Power J, French R, Cowan FM (2007) Subdermal implantable contraceptives versus other forms of reversible contraceptives or other implants as effective methods for preventing pregnancy. Cochrane Database Syst Rev 3, CD001326. doi:10.1002/14651858, CD001326.pub2

    PubMed  Google Scholar 

  • Rekers H (2013) Removal of a fractured Nexplanon: MSD response. J Fam Plann Reprod Health Care 39(1):67

    PubMed  Google Scholar 

  • Roberts TE, Tsourapas A, Middleton LJ, Champaneria R, Daniels JP, Cooper KG et al (2011) Hysterectomy, endometrial ablation, and levonorgestrel releasing intrauterine system (Mirena) for treatment of heavy menstrual bleeding: cost effectiveness analysis. BMJ (Online) 342(7804):30

    Google Scholar 

  • Rossing MA, Daling JR, Voigt LF, Stergachis AS, Weiss NS (1993) Current use of an intrauterine device and risk of tubal pregnancy. Epidemiology 4(3):252–258

    CAS  PubMed  Google Scholar 

  • Rowlands S (2010a) Legal aspects of contraceptive implants. J Fam Plann Reprod Health Care 36(4):243–248

    PubMed  Google Scholar 

  • Rowlands S (2010b) Lost IUD, penetrating bladder wall. J Fam Plann Reprod Health Care 36(4):178–182

    Google Scholar 

  • Rowlands S, Sujan MA, Cooke M (2010) A risk management approach to the design of contraceptive implants. J Fam Plann Reprod Health Care 36(4):191–195

    PubMed  Google Scholar 

  • Saleh S, Ahmad G, Majumdar A (2011) Group A streptococcus necrotisising fasciitis from a levonorgestrel containing intrauterine system (‘Mirena’ coil). J Obstet Gynaecol 31(2):192–194

    CAS  PubMed  Google Scholar 

  • Sarkar P (2000) Translocation of a Copper 7 intra-uterine contraceptive device with subsequent penetration of the caecum: case report and review. Br J Fam Plann 26(3):161

    CAS  PubMed  Google Scholar 

  • Schnabel P, Merki-Feld GS, Malvy A, Duijkers I, Mommers E, van den Heuvel MW (2012) Bioequivalence and x-ray visibility of a radiopaque etonogestrel implant versus a non-radiopaque implant: a 3-year, randomized, double-blind study. Clin Drug Investig 32(6):413–422

    PubMed  Google Scholar 

  • Sheng J, Zhang WY, Zhang JP, Lu D (2009) The LNG-IUS study on adenomyosis: a 3-year follow-up study on the efficacy and side effects of the use of the levonorgestrel intrauterine system for the treatment of dysmenorrhoea associated with adenomyosis. Contraception 79:189–193

    CAS  PubMed  Google Scholar 

  • Short M, Dallay D, Omokanye S, Stauch K, Inki P (2014) Acceptability of long-acting, progestin-only contraception in Europe: a two-year prospective, non-interventional study. Eur J Contracept Reprod Health Care 19(1):29–38

    CAS  PubMed  Google Scholar 

  • Sidney S, Cheetham TC, Connell FA, Ouellet-Hellstrom R, Graham DJ, Davis D et al (2013) Recent combined hormonal contraceptives (CHCs) and the risk of thromboembolism and other cardiovascular events in new users. Contraception 87(1):93–100

    CAS  PubMed  Google Scholar 

  • Silva-Filho AL, Pereira FA, de Souza SS, Loures LF, Rocha AP, Valadares CN et al (2013) Five-year follow-up of levonorgestrel-releasing intrauterine system versus thermal balloon ablation for the treatment of heavy menstrual bleeding: a randomized controlled trial. Contraception 87(4):409–415

    CAS  PubMed  Google Scholar 

  • Singh M, Mansour D, Richardson D (2006) Location and non-palpable Implanon implants with the aid of ultrasound guidance. J Fam Plann Reprod Health Care 32:153–156

    PubMed  Google Scholar 

  • Sivin I (1993) Another look at the Dalkon Shield: meta-analysis underscores its problems. [Erratum appears in Contraception 1993 48(2):192]. Contraception 48(1):1–12

    Google Scholar 

  • Sivin I, Stern J, Coutinho E, Mattos CER, el Mahgoub S, Diaz S et al (1991) Prolonged intrauterine contraception: a seven-year randomized study of the levonorgestrel 20 mcg/day (LNg 20) and the copper T380 Ag IUDs. Contraception 44(5):473–480

    CAS  PubMed  Google Scholar 

  • Sivin I, Stern J, Diaz S, Pavez M, Alvarez F, Brache V et al (1992) Rates and outcomes of planned pregnancy after use of Norplant capsules, Norplant II rods, or levonorgestrel releasing or copper TCu 380Ag intrauterine contraceptive devices. Am J Obstet Gynecol 166(4):1208–1213

    CAS  PubMed  Google Scholar 

  • Sivin I, Diaz S, Croxatto HB, Miranda P, Shaaban M, Sayed EH et al (1997) Contraceptives for lactating women: a comparative trial of a progesterone-releasing vaginal ring and the Copper T 380A IUD. Contraception 55(4):225–232

    CAS  PubMed  Google Scholar 

  • Sivin I, Mishell DR, Darney P, Wan L, Christ M (1998a) Levonorgestrel capsule implant in the United States: a 5 year study. Obstet Gynecol 92:337–344

    CAS  PubMed  Google Scholar 

  • Sivin I, Campodonico I, Kiriway O (1998b) The performance of levonorgestrel rod and Norplant contraceptive implant: a 5-year randomised study. Hum Reprod 13:3371–3378

    CAS  PubMed  Google Scholar 

  • Sivin I, Nash H, Waldman S (2002) In: Population Council (ed) Jadelle® levonorgestrel rod implants: a summary of scientific data and lessons learned from programmatic experience. Population Council, New York

    Google Scholar 

  • Skjeldestad FE (1997) How effectively do copper intrauterine devices prevent ectopic pregnancy? Acta Obstet Gynecol Scand 76(7):684–690

    CAS  PubMed  Google Scholar 

  • Skjeldestad FE, Hammervold R, Peterson DR (1988) Outcomes of pregnancy with an IUD in situ – a population based case-control study. Adv Contracept 4(4):265–270

    CAS  PubMed  Google Scholar 

  • Steenland MW, Zapata LB, Brahmi D, Marchbanks PA, Curtis KM (2013) Appropriate follow up to detect potential adverse events after initiation of select contraceptive methods: a systematic review. [Review]. Contraception 87(5):611–624

    PubMed  Google Scholar 

  • Steiner MJ, Lopez LM, Grimes DA, Cheng L, Shelton J, Trussell J et al (2010) Sino-implant (II)–a levonorgestrel-releasing two-rod implant: systematic review of the randomized controlled trials. [Review] [26 refs]. Contraception 81(3):197–201

    CAS  PubMed Central  PubMed  Google Scholar 

  • Strom BL, Berlin JA, Weber AL, Norman SA, Bernstein L, Burkman RT et al (2004) Absence of an effect of injectable and implantable progestin-only contraceptives on subsequent risk of breast cancer. Contraception 69(5):353–360

    CAS  PubMed  Google Scholar 

  • Suvisaari J, Lahteenmaki P (1996) Detailed analysis of menstrual bleeding patterns after postmenstrual and postabortal insertion of a copper IUD or a levonorgestrel-releasing intrauterine system. Contraception 54:201–208

    CAS  PubMed  Google Scholar 

  • Tanmahasamut P, Rattanachaiyanont M, Angsuwathana S, Techatraisak K, Indhavivadhana S, Leerasiri P (2012) Postoperative levonorgestrel-releasing intrauterine system for pelvic endometriosis-related pain: a randomized controlled trial. Obstet Gynecol 119(3):519–526

    PubMed  Google Scholar 

  • Tekin Y, Dilbaz B, Altinbas SK, Dilbaz S (2011) Postoperative medical treatment of chronic pelvic pain related to severe endometriosis: levonorgestrel-releasing intrauterine system versus gonadotropin-releasing hormone analogue. Fertil Steril 95(2):492–496

    Google Scholar 

  • Tepper NK, Steenland MW, Gaffield ME, Marchbanks PA, Curtis KM (2013) Retention of intrauterine devices in women who acquire pelvic inflammatory disease: a systematic review. [Review]. Contraception 87(5):655–660

    PubMed  Google Scholar 

  • Toivonen J, Luukkainen T, Allonen H (1991) Protective effect of intrauterine release of levonorgestrel on pelvic infection: three years experience of levonorgestrel- and copper-releasing intrauterine devices. Obstet Gynecol 77(2):261–264

    CAS  PubMed  Google Scholar 

  • Torres R, Mendes N, Machado AI, Marques C (2013) In situ breakage of Implanon – two cases of a rare occurrence. Contraception 88(1):189–191

    PubMed  Google Scholar 

  • Tyler CP, Whiteman MK, Zapata LB, Curtis KM, Hillis SD, Marchbanks PA (2012) Health care provider attitudes and practices related to intrauterine devices for nulliparous women. Obstet Gynecol 119(4):762–771

    PubMed  Google Scholar 

  • United Nations, Department of Economic and Social Affairs, Population Division (2013) World contraceptive use 2012

    Google Scholar 

  • Urbancsek J (1998) An integrated analysis of nonmenstrual adverse events with Implanon. Contraception 58:109S–115S

    CAS  PubMed  Google Scholar 

  • van Grootheest K, Sachs B, Harrison-Woolrych M, Caduff-Janosa P, van Puijenbroek E (2011) Uterine perforation with the levonorgestrel-releasing intrauterine device. Analysis of reports from four national pharmacovigilance centres. Drug Saf 34(1):83–88

    PubMed  Google Scholar 

  • Venkataramanasetty R, Aburawi A, Phillip H (2009) Streptococcal toxic shock syndrome following insertion of an intrauterine device–a case report. Eur J Contracept Reprod Health Care 14(5):379–382

    CAS  PubMed  Google Scholar 

  • Vessey MP, Johnson B, Doll R, Peto R (1974) Outcome of pregnancy in women using an intrauterine device. Lancet 1(7856):495–498

    CAS  PubMed  Google Scholar 

  • Vessey MP, Lawless M, McPherson K, Yeates D (1983) Fertility after stopping use of intrauterine contraceptive device. Br Med J 286(6359):106

    CAS  Google Scholar 

  • Vidin E, Garbin O, Rodriguez B, Favre R, Bettahar-Lebugle K (2007) Removal of etonogestrel contraceptive implants in the operating theater: report on 28 cases. Contraception 76(1):35–39

    PubMed  Google Scholar 

  • Walch K, Unfried G, Huber J, Kurz C, van Trotsenburg M, Pernicka E et al (2009) Implanon versus medroxyprogesterone acetate: effects on pain scores in patients with symptomatic endometriosis- a pilot study. Contraception 79:29–34

    CAS  PubMed  Google Scholar 

  • Walling M (2005) How to remove impalpable Implanon(R) implants. J Fam Plann Reprod Health Care 31(4):320–321

    PubMed  Google Scholar 

  • Wan YL, Holland C (2011) The efficacy of levonorgestrel intrauterine systems for endometrial protection: a systematic review. [Review]. Climacteric 14(6):622–632

    CAS  PubMed  Google Scholar 

  • Whiteman MK, Tyler CP, Folger SG, Gaffield ME, Curtis KM (2013) When can a woman have an intrauterine device inserted? A systematic review. [Review]. Contraception 87(5):666–673

    PubMed  Google Scholar 

  • World Health Organization (1985) A multinational case-control study of ectopic pregnancy. Clin Reprod Fertil 3:131–143

    Google Scholar 

  • Wilson JC (1989) A prospective New Zealand study of fertility after removal of copper intrauterine contraceptive devices for conception and because of complications: a four year study. Am J Obstet Gynecol 160(2):391–396

    CAS  PubMed  Google Scholar 

  • Wong RC, Bell RJ, Thunuguntla K, McNamee K, Vollenhoven B (2009) Implanon users are less likely to be satisfied with their contraception after 6 months than IUD users. Contraception 80(5):452–456

    PubMed  Google Scholar 

  • World Health Organization (1987) Mechanism of action, safety and efficacy of intrauterine devices, Report no.: technical report series 753. WHO, Geneva

    Google Scholar 

  • World Health Organization (2010) Medical eligibility criteria for contraceptive use 4th edition 2009, 4th edn. WHO, Geneva. http://www.who.int/reproductivehealth/publications/family_planning/9789241563888/en/index.html

  • Xiong X, Buekens P, Wollast E (1995) IUD use and the risk of ectopic pregnancy: a meta-analysis of case-control studies. Contraception 52:23–34

    CAS  PubMed  Google Scholar 

  • Xu H, Wade JA, Peipert JF, Zhao Q, Madden T, Secura GM (2012) Contraceptive failure rates of etonogestrel subdermal implants in overweight and obese women. Obstet Gynecol 120(1):21–26

    CAS  PubMed Central  PubMed  Google Scholar 

  • Yildizbas B, Sahin GH, Kolusari A, Zeteroglu S, Kamaci M (2007) Side effects and acceptability of Implanon: a pilot study conducted in eastern Turkey. Eur J Contracept Reprod Health Care 12(3):248–252

    CAS  PubMed  Google Scholar 

  • Yisa SB, Okenwa AA, Husemeyer R (2005) Treatment of pelvic endometriosis with etonogestrel subdermal implant (Implanon). J Fam Plann Reprod Health Care 31(1):67–70

    PubMed  Google Scholar 

  • Zakin D, Stern WZ, Rosenblatt R (1981) Complete and partial uterine perforation and embedding following insertion of intrauterine devices. II. Diagnostic methods, prevention, management. Obstet Gynecol Surv 36(8):401–417

    CAS  PubMed  Google Scholar 

  • Zerner J, Doil KL, Drewry J, Leeber DA (1981) Intrauterine contraceptive device failures in renal transplant patients. J Reprod Med 26(2):99–102

    CAS  PubMed  Google Scholar 

  • Zheng SR, Zheng HM, Qian SZ, Sang GW, Kaper RF (1999) A randomized multicenter study comparing the efficacy and bleeding pattern of a single-rod (Implanon) and a six-capsule (Norplant) hormonal contraceptive implant. Contraception 60:1–8

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Sandyford Sexual Health Service, NHS Greater Glasgow and Clyde, 2-6 Sandyford Place, Glasgow, G3 7NB, UK

    Julie Craik

  2. School of Health and Social Care, Bournemouth University, R506 Royal London House, Christchurch Road, Bournemouth, BH1 3LT, UK

    Sam Rowlands

Authors
  1. Julie Craik
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sam Rowlands
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Julie Craik .

Editor information

Editors and Affiliations

  1. Dean’s Department, Dunedin School of Medicine, University of Otago, Dunedin, New Zealand

    Mira Harrison-Woolrych

Rights and permissions

Reprints and permissions

Copyright information

© 2015 Springer International Publishing Switzerland

About this chapter

Cite this chapter

Craik, J., Rowlands, S. (2015). Contraceptive Devices for Women: Implants, Intrauterine Devices and Other Products. In: Harrison-Woolrych, M. (eds) Medicines For Women. Adis, Cham. https://doi.org/10.1007/978-3-319-12406-3_8

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-12406-3_8

  • Published:

  • Publisher Name: Adis, Cham

  • Print ISBN: 978-3-319-12405-6

  • Online ISBN: 978-3-319-12406-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation